Your browser doesn't support javascript.
loading
Ten-year safety and clinical benefit from open-label etanercept treatment in children and young adults with juvenile idiopathic arthritis.
Vojinovic, Jelena; Foeldvari, Ivan; Dehoorne, Joke; Panaviene, Violeta; Susic, Gordana; Horneff, Gerd; Stanevicha, Valda; Kobusinska, Katarzyna; Zuber, Zbigniew; Dobrzyniecka, Bogna; Akikusa, Jonathan; Avcin, Tadej; Borlenghi, Cecilia; Arthur, Edmund; Tatulych, Svitlana Y; Zang, Chuanbo; Tsekouras, Vassilis; Vlahos, Bonnie; Martini, Alberto; Ruperto, Nicolino.
Afiliación
  • Vojinovic J; Department of Pediatric Immunology and Rheumatology, Faculty of Medicine, University of Nis, Nis, Serbia.
  • Foeldvari I; Hamburg Centre for Pediatric Rheumatology, Hamburg, Germany.
  • Dehoorne J; Department of Pediatric Rheumatology, Ghent University Hospital, Ghent, Belgium.
  • Panaviene V; Children's Hospital, Affiliate of Vilnius University Hospital Santaros Clinic, Vilnius, Lithuania.
  • Susic G; Clinic of Children's Diseases, Vilnius University, Vilnius, Lithuania.
  • Horneff G; Department of Pediatric Rheumatology, University Children's Hospital, Institute of Rheumatology, Belgrade, Serbia.
  • Stanevicha V; Department of General Paediatrics, Asklepios Clinic Sankt Augustin, Sankt Augustin, Germany.
  • Kobusinska K; Department of Paediatric and Adolescents Medicine, University Hospital of Cologne, Medical Faculty, Cologne, Germany.
  • Zuber Z; Riga Stradins University, Children's University Hospital, Riga, Latvia.
  • Dobrzyniecka B; Provincial Children's Hospital J. Brudzinskiego, Bydgoszcz, Poland.
  • Akikusa J; Andrzej Frycz Modrzewski Krakow University, Krakow, Poland.
  • Avcin T; A. Falkiewicz's Specialist Hospital, Wroclaw, Poland.
  • Borlenghi C; Pediatric Rheumatology, Royal Children's Hospital, Melbourne, Australia.
  • Arthur E; Department of Allergology, Rheumatology and Clinical Immunology, University Children's Hospital, University Medical Centre, Ljubljana, Slovenia.
  • Tatulych SY; Pfizer, Buenos Aires, Argentina.
  • Zang C; Pfizer, Peapack, NJ, USA.
  • Tsekouras V; Pfizer, Groton, CT, USA.
  • Vlahos B; Pfizer, Collegeville, PA, USA.
  • Martini A; Hellas (Cyprus Branch), Pfizer, Nicosia, Cyprus.
  • Ruperto N; Pfizer, Collegeville, PA, USA.
Rheumatology (Oxford) ; 63(1): 140-148, 2024 Jan 04.
Article en En | MEDLINE | ID: mdl-37140539
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Artritis Juvenil / Artritis Psoriásica / Antirreumáticos / Neoplasias Tipo de estudio: Risk_factors_studies Límite: Adolescent / Adult / Child / Child, preschool / Humans Idioma: En Año: 2024 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Artritis Juvenil / Artritis Psoriásica / Antirreumáticos / Neoplasias Tipo de estudio: Risk_factors_studies Límite: Adolescent / Adult / Child / Child, preschool / Humans Idioma: En Año: 2024 Tipo del documento: Article